Scarica l'app Stockscreener
4.55
3.17%
0.14
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché SONN Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.41
Aprire:
$4.28
Volume 24 ore:
633.86K
Relative Volume:
0.72
Capitalizzazione di mercato:
$32.20M
Reddito:
$129.20K
Utile/perdita netta:
$-7.44M
Rapporto P/E:
-0.4066
EPS:
-11.19
Flusso di cassa netto:
$-8.62M
1 W Prestazione:
-23.14%
1M Prestazione:
+16.97%
6M Prestazione:
+279.17%
1 anno Prestazione:
+57.44%
Intervallo 1D:
$3.95
$4.5799
Intervallo di 1 settimana:
$3.95
$5.95
Portata 52W:
$1.08
$19.30
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Company Profile
Nome
Sonnet Biotherapeutics Holdings Inc
Settore
Industria
Telefono
609-375-2227
Indirizzo
100 OVERLOOK CENTER, PRINCETON, NJ
Confronta SONN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SONN
Sonnet Biotherapeutics Holdings Inc
|
4.55 | 30.11M | 129.20K | -7.44M | -8.62M | -11.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Sonnet Biotherapeutics Holdings Inc Borsa (SONN) Ultime notizie
Regression analysis insights on Sonnet BioTherapeutics Holdings Inc. performanceMarket Sentiment Report & AI Based Trade Execution Alerts - newser.com
Why Sonnet BioTherapeutics Holdings Inc. stock could benefit from AI revolution2025 Market Outlook & Weekly High Conviction Ideas - newser.com
Published on: 2025-11-20 06:58:46 - newser.com
Is Sonnet BioTherapeutics Holdings Inc. stock a buy on dipsSell Signal & Precise Swing Trade Entry Alerts - newser.com
Can Sonnet BioTherapeutics Holdings Inc. stock rebound after recent weaknessJuly 2025 EndofMonth & Long-Term Safe Investment Ideas - newser.com
Is Sonnet BioTherapeutics Holdings Inc. stock a good choice for value investors2025 Buyback Activity & Stepwise Entry and Exit Trade Signals - newser.com
Can Sonnet BioTherapeutics Holdings Inc. stock outperform in 2025 bull market - newser.com
What high frequency data says about Sonnet BioTherapeutics Holdings Inc. - newser.com
Using data models to predict Sonnet BioTherapeutics Holdings Inc. stock movementWeekly Investment Summary & Low Risk High Reward Trade Ideas - newser.com
Sentiment analysis tools applied to Sonnet BioTherapeutics Holdings Inc.Portfolio Gains Summary & Free Safe Entry Trade Signal Reports - newser.com
Is Sonnet BioTherapeutics Holdings Inc. meeting your algorithmic filter criteriaJuly 2025 Technicals & Real-Time Volume Triggers - newser.com
How risky is Sonnet BioTherapeutics Holdings Inc. stock nowQuarterly Earnings Summary & Reliable Price Breakout Signals - newser.com
A Fresh $16 Million Bet on ImmunityBio: What Investors Should Know - The Motley Fool
Will Sonnet BioTherapeutics Holdings Inc. stock reach Wall Street targets2025 Valuation Update & Fast Exit and Entry Trade Guides - newser.com
What momentum shifts mean for Sonnet BioTherapeutics Holdings Inc.Market Trend Report & Fast Exit Strategy with Risk Control - newser.com
Will Sonnet BioTherapeutics Holdings Inc. outperform the marketJuly 2025 EndofMonth & Safe Capital Growth Tips - newser.com
Sonnet Pushes Merger Vote as Support Grows for $1B Hyperliquid Venture - CoinCentral
Sonnet BioTherapeutics (SONN) Delays Shareholder Vote on Key Bus - GuruFocus
Sonnet BioTherapeutics Adjourns Meeting for Business Combination - TipRanks
[425] Sonnet BioTherapeutics Holdings, Inc. Business Combination Communication | SONN SEC FilingForm 425 - Stock Titan
[8-K] Sonnet BioTherapeutics Holdings, Inc. Reports Material Event | SONN SEC FilingForm 8-K - Stock Titan
Sonnet BioTherapeutics Holdings, Inc. Announces Adjournment of Special Meeting - The Manila Times
Sonnet Bio (NASDAQ: SONN) gets 95% support as merger vote delayed to Dec 2025 - Stock Titan
What recovery options are there for Sonnet BioTherapeutics Holdings Inc.July 2025 Summary & Expert Approved Trade Ideas - newser.com
Tools to assess Sonnet BioTherapeutics Holdings Inc.’s risk profile2025 Fundamental Recap & Fast Gain Swing Trade Alerts - newser.com
What sentiment indicators say about Sonnet BioTherapeutics Holdings Inc. stockEarnings Overview Summary & Momentum Based Trading Signals - newser.com
Is Sonnet BioTherapeutics Holdings Inc. stock attractive for retirement portfoliosJuly 2025 Outlook & Growth Focused Entry Reports - newser.com
Sonnet BioTherapeutics Holdings, Inc.Common Stock (NQ: SONN - FinancialContent
Published on: 2025-11-16 06:57:13 - newser.com
Chart based analysis of Sonnet BioTherapeutics Holdings Inc. trendsMarket Trend Summary & Community Verified Trade Signals - newser.com
Is Sonnet BioTherapeutics Holdings Inc. stock trading at a premium valuationJuly 2025 Macro Moves & Daily Growth Stock Investment Tips - newser.com
Applying big data sentiment scoring on Sonnet BioTherapeutics Holdings Inc.Insider Buying & Stepwise Trade Signal Guides - newser.com
Published on: 2025-11-15 21:07:33 - newser.com
Can Sonnet BioTherapeutics Holdings Inc. stock sustain revenue growthDollar Strength & Community Supported Trade Ideas - newser.com
Sonnet Biotherapeutics Holdings Inc Azioni (SONN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):